Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a medical device company dedicated to improving the lives of people with diabetes through innovative insulin delivery systems and integrated software solutions. Founded in 2006 and headquartered in San Diego, California, Tandem designs, develops, and commercializes insulin pumps and technology platforms that enable better diabetes management. Since its initial public offering, the company has focused on combining sleek design, intuitive user interfaces, and advanced algorithms to streamline insulin therapy for patients worldwide.
The company’s flagship product, the t:slim X2® Insulin Pump, features a color touchscreen, rechargeable battery, and the ability to receive software updates without hardware replacement. Tandem has also introduced automated insulin delivery algorithms—Basal-IQ™ and Control-IQ™ technology—that integrate with continuous glucose monitoring (CGM) systems to predict and respond to glucose fluctuations. These systems offer features such as automated basal adjustments, correction boluses, and hypoglycemia prevention, empowering users with more precise control over their blood sugar levels.
Tandem Diabetes Care markets its products directly to patients, caregivers, and healthcare professionals through a dedicated sales force, distribution partners, and online channels. The company’s reach extends across the United States, Europe, Canada, Australia, and select markets in Asia and Latin America. By forging collaborative partnerships with payers, healthcare providers, and advocacy organizations, Tandem aims to expand access to its technology and support improved outcomes for people living with both type 1 and type 2 diabetes.
Led by founder and Chief Executive Officer John Sheridan, Tandem Diabetes Care maintains a strong focus on research and development, regulatory compliance, and customer service. The company’s leadership team includes seasoned professionals in engineering, operations, and finance who work together to drive innovation and operational excellence. As the diabetes technology market evolves, Tandem continues to invest in software enhancements, data analytics, and next-generation hardware to meet the needs of its growing customer base and uphold its mission of delivering life-changing solutions for diabetes management.
AI Generated. May Contain Errors.
Free TNDM Stock Alerts